received FDA 510(k) clearance for its advanced surgical solution, BIASURGE. This wound type segment is bifurcated into acute wounds (surgical wounds, traumatic wounds, and burns) and chronic wounds ...
The U.S. Advanced Wound Care market has demonstrated strong growth, with its valuation at $3.35 billion in 2019, and projections suggest it will reach $4.97 billion by 2027. This ...